Background Nonalcoholic fatty liver disease (NAFLD) is a chronic condition characterized by
a progressive decline in liver function, leading to disruptions in liver integrity and metabolic …

Non-alcoholic fatty liver disease (NAFLD), currently the leading cause of global chronic liver
disease, has emerged as a major public health problem, more efficient therapeutics of which …

Nonalcoholic fatty liver disease (NAFLD), a form of chronic liver disease that occurs in
individuals with no significant alcohol abuse, has become an increasing concern for global …

Non-alcoholic fatty liver disease (NAFLD) is a major health issue in developed countries.
Although usually associated with obesity, NAFLD is also diagnosed in individuals with low …

Non-alcoholic fatty liver disease (NAFLD) is a liver pathology with increasing prevalence
due to the obesity epidemic. Hence, NAFLD represents a rising threat to public health …

ABSTRACT NAFLD is a condition that develops when the liver accumulates excess fat
without alcohol consumption. This chronic liver ailment progresses along with insulin …

Background & Aims Nonalcoholic steatohepatitis (NASH) is commonly observed in patients
with type 2 diabetes, and thiazolidinediones (TZD) are considered a potential therapy for …

Lately, the world has faced tremendous progress in the understanding of non-alcoholic fatty
liver disease (NAFLD) pathogenesis due to rising obesity rates. Peroxisome proliferator …

Non-alcoholic steatohepatitis (NASH) is characterized by macrovesicular steatosis with
ballooning degeneration of hepatocytes, diffused lobular inflammation, and fibrosis. PPAR …

Nonalcoholic fatty liver disease (NAFLD) is increasingly prevalent and strongly associated
with central obesity, dyslipidemia, and insulin resistance. According to the multiple-hit model …